Published in:

01-09-2001 | Short communication

Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease – preterax and diamicron MR controlled evaluation

Authors: , ADVANCE Management Committee

Published in: Diabetologia | Issue 9/2001